A Phase 3, Multi-centric, Single blind, Randomized, Comparative study to assess the efficacy and safety of fixed dose combination of Telmisartan + Amlodipine + Hydrochlorothiazide bi-layered tablet verses Telmisartan + Hydrochlorothiazide tablet for the treatment in patients with essential hypertension.

Trial Profile

A Phase 3, Multi-centric, Single blind, Randomized, Comparative study to assess the efficacy and safety of fixed dose combination of Telmisartan + Amlodipine + Hydrochlorothiazide bi-layered tablet verses Telmisartan + Hydrochlorothiazide tablet for the treatment in patients with essential hypertension.

Completed
Phase of Trial: Phase III

Latest Information Update: 02 Sep 2016

At a glance

  • Drugs Amlodipine/telmisartan/hydrochlorothiazide (Primary) ; Telmisartan/hydrochlorothiazide
  • Indications Essential hypertension
  • Focus Therapeutic Use
  • Sponsors Aristo Pharmaceuticals
  • Most Recent Events

    • 10 Jun 2013 Status changed from recruiting to completed as reported by Clinical Trials Registry - India record.
    • 05 Jun 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top